KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

West Pharmaceutical Services (WST) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to $5.1 million.

  • West Pharmaceutical Services' Interest & Investment Income rose 625.0% to $5.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $17.5 million, marking a year-over-year decrease of 1071.43%. This contributed to the annual value of $17.5 million for FY2025, which is 1071.43% down from last year.
  • West Pharmaceutical Services' Interest & Investment Income amounted to $5.1 million in Q4 2025, which was up 625.0% from $4.7 million recorded in Q3 2025.
  • Over the past 5 years, West Pharmaceutical Services' Interest & Investment Income peaked at $9.4 million during Q4 2023, and registered a low of $100000.0 during Q1 2021.
  • In the last 5 years, West Pharmaceutical Services' Interest & Investment Income had a median value of $4.0 million in 2024 and averaged $3.6 million.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first crashed by 8750.0% in 2021, then soared by 150000.0% in 2023.
  • Over the past 5 years, West Pharmaceutical Services' Interest & Investment Income (Quarter) stood at $300000.0 in 2021, then surged by 866.67% to $2.9 million in 2022, then skyrocketed by 224.14% to $9.4 million in 2023, then plummeted by 48.94% to $4.8 million in 2024, then rose by 6.25% to $5.1 million in 2025.
  • Its Interest & Investment Income was $5.1 million in Q4 2025, compared to $4.7 million in Q3 2025 and $3.6 million in Q2 2025.